129 related articles for article (PubMed ID: 16204716)
1. Glucose-normalized standardized uptake value from (18)F-FDG PET in classifying lymphomas.
Wong CY; Thie J; Parling-Lynch KJ; Zakalik D; Margolis JH; Gaskill M; Hill J; Qing F; Fink-Bennett D; Nagle C
J Nucl Med; 2005 Oct; 46(10):1659-63. PubMed ID: 16204716
[TBL] [Abstract][Full Text] [Related]
2. Investigating the existence of quantum metabolic values in non-Hodgkin's lymphoma by 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography.
Wong CY; Thie J; Parling-Lynch KJ; Zakalik D; Wong RH; Gaskill M; Margolis JH; Hill J; Sukari A; Chundru S; Fink-Bennett D; Nagle C
Mol Imaging Biol; 2007; 9(1):43-9. PubMed ID: 17176979
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
4. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
Tsujikawa T; Otsuka H; Morita N; Saegusa H; Kobayashi M; Okazawa H; Nishitani H
Ann Nucl Med; 2008 Jan; 22(1):23-30. PubMed ID: 18250984
[TBL] [Abstract][Full Text] [Related]
5. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
6. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
7. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
8. Is liver SUV stable over time in ¹⁸F-FDG PET imaging?
Laffon E; Adhoute X; de Clermont H; Marthan R
J Nucl Med Technol; 2011 Dec; 39(4):258-63. PubMed ID: 21878481
[TBL] [Abstract][Full Text] [Related]
9. Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.
Yamane T; Daimaru O; Ito S; Yoshiya K; Nagata T; Ito S; Uchida H
J Nucl Med; 2004 Nov; 45(11):1838-42. PubMed ID: 15534052
[TBL] [Abstract][Full Text] [Related]
10. Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.
Hutchings M; Loft A; Hansen M; Ralfkiaer E; Specht L
Hematol Oncol; 2006 Sep; 24(3):146-50. PubMed ID: 16729353
[TBL] [Abstract][Full Text] [Related]
11. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
12. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
13. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.
Lin C; Itti E; Haioun C; Petegnief Y; Luciani A; Dupuis J; Paone G; Talbot JN; Rahmouni A; Meignan M
J Nucl Med; 2007 Oct; 48(10):1626-32. PubMed ID: 17873129
[TBL] [Abstract][Full Text] [Related]
14. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.
Schöder H; Noy A; Gönen M; Weng L; Green D; Erdi YE; Larson SM; Yeung HW
J Clin Oncol; 2005 Jul; 23(21):4643-51. PubMed ID: 15837966
[TBL] [Abstract][Full Text] [Related]
15. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG uptake and clearance in patients with compromised renal function.
Akers SR; Werner TJ; Rubello D; Alavi A; Cheng G
Nucl Med Commun; 2016 Aug; 37(8):825-32. PubMed ID: 27058366
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the normal adrenal gland with 18F-FDG PET/CT.
Bagheri B; Maurer AH; Cone L; Doss M; Adler L
J Nucl Med; 2004 Aug; 45(8):1340-3. PubMed ID: 15299059
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET of common enhancing malignant brain tumors.
Kosaka N; Tsuchida T; Uematsu H; Kimura H; Okazawa H; Itoh H
AJR Am J Roentgenol; 2008 Jun; 190(6):W365-9. PubMed ID: 18492879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
